Trial of dichloroacetate in MELAS: toxicity overshadows the assessment of potential benefit

Neurology. 2006 Feb 14;66(3):302-3. doi: 10.1212/01.wnl.0000202411.14371.e0.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Dichloroacetic Acid / adverse effects*
  • Dichloroacetic Acid / therapeutic use
  • Humans
  • MELAS Syndrome / drug therapy*
  • Randomized Controlled Trials as Topic

Substances

  • Dichloroacetic Acid